Drug Profile
Gantofiban
Alternative Names: EMD 122347; YM 028Latest Information Update: 08 Jun 2004
Price :
$50
*
At a glance
- Originator Merck KGaA; Yamanouchi
- Class Antithrombotics; Oxazoles; Piperazines; Small molecules; Vascular disorder therapies
- Mechanism of Action GPIIb-IIIa antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 13 May 2004 Discontinued - Phase-II for Thrombosis in Japan (PO)
- 20 Oct 2003 This compound is still in active development
- 22 Jul 2002 Phase-II clinical trials in Thrombosis in Japan (PO)